Colgate-Palmolive Co (CL) financial statements: income statement, balance sheet and cash flow

Colgate-Palmolive Co's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Colgate-Palmolive Co reported revenue of $20.4B (+1.4% year on year) and net income of $2.1B (-26.2% year on year).

Income statement

Colgate-Palmolive Co income statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Net sales	$20.4B	$20.1B	$19.5B	$18.0B
Cost of sales	$8.1B	$7.9B	$8.1B	$7.7B
Gross profit	$12.3B	$12.2B	$11.3B	$10.2B
Selling, general and administrative expenses	$7.9B	$7.7B	$7.2B	$6.6B
Other (income) expense, net	$123.0M	$164.0M	$191.0M	$69.0M
Goodwill and intangible assets impairment charges	$919.0M	$0	$0	$721.0M
Operating profit	$3.3B	$4.3B	$4.0B	$2.9B
Non-service related postretirement costs	$55.0M	$87.0M	$360.0M	$80.0M
Interest expense	$267.0M	$292.0M	—	—
Interest income	$75.0M	$67.0M	—	—
Income before income taxes	$3.1B	$4.0B	$3.4B	$2.7B
Global effective tax rate	798000000.0%	907000000.0%	937000000.0%	693000000.0%
Net income including noncontrolling interests	$2.3B	$3.0B	$2.5B	$2.0B
Less: Net income attributable to noncontrolling interests	$129.0M	$160.0M	$155.0M	$182.0M
Net income attributable to Colgate-Palmolive Company	$2.1B	$2.9B	$2.3B	$1.8B
Earnings per common share, basic (in dollars per share)	$2.64	$3.53	$2.78	$2.13
Earnings per common share, diluted (in dollars per share)	$2.63	$3.51	$2.77	$2.13

Colgate-Palmolive Co income statement, quarters

Line item	Jun 30, 2026 · Q2	Mar 31, 2026 · Q1	Sep 30, 2025 · Q3	Jun 30, 2025 · Q2
Net sales	$5.4B	$5.3B	$5.1B	$5.1B
Cost of sales	$2.1B	$2.1B	$2.1B	$2.0B
Gross profit	$3.3B	$3.2B	$3.0B	$3.1B
Selling, general and administrative expenses	$2.1B	$2.1B	$2.0B	$2.0B
Other (income) expense, net	$150.0M	$186.0M	$19.0M	$26.0M
Operating profit	$1.0B	$964.0M	$1.1B	$1.1B
Non-service related postretirement costs	$21.0M	$26.0M	$21.0M	$23.0M
Interest expense	$62.0M	$62.0M	$67.0M	$71.0M
Interest income	$17.0M	$16.0M	$21.0M	$21.0M
Income before income taxes	$950.0M	$892.0M	$992.0M	$1.0B
Provision for income taxes	$231.0M	$211.0M	$226.0M	$234.0M
Net income including noncontrolling interests	$719.0M	$681.0M	$766.0M	$773.0M
Less: Net income attributable to noncontrolling interests	$26.0M	$35.0M	$31.0M	$30.0M
Net income attributable to Colgate-Palmolive Company	$693.0M	$646.0M	$735.0M	$743.0M
Earnings per common share, basic (in dollars per share)	$0.87	$0.81	$0.91	$0.92
Earnings per common share, diluted (in dollars per share)	$0.86	$0.80	$0.91	$0.91

Balance sheet

Colgate-Palmolive Co balance sheet, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Cash and cash equivalents	$1.3B	$1.1B	$966.0M	$775.0M
Receivables (net of allowances of $90 and $85, respectively)	$1.7B	$1.5B	$1.6B	$1.5B
Inventories	$2.0B	$2.0B	$1.9B	$2.1B
Other current assets	$714.0M	$713.0M	$793.0M	$760.0M
Total current assets	$5.7B	$5.3B	$5.3B	$5.1B
Property, plant and equipment, net	$4.7B	$4.4B	$4.6B	$4.3B
Goodwill	$3.1B	$3.3B	$3.4B	$3.4B
Other intangible assets, net	$1.5B	$1.8B	$1.9B	$1.9B
Deferred income taxes	$205.0M	$195.0M	$214.0M	$135.0M
Other non-current assets	$1.1B	$1.1B	$1.0B	$904.0M
Total assets	$16.3B	$16.0B	$16.4B	$15.7B
Debt payable within one-year	$1.1B	$660.0M	$310.0M	$11.0M
Accounts payable	$2.1B	$1.8B	$1.7B	$1.6B
Accrued income taxes	$383.0M	$403.0M	$336.0M	$317.0M
Other accruals	$3.3B	$2.9B	$2.4B	$2.1B
Total current liabilities	$6.9B	$5.8B	$4.7B	$4.0B
Long-term debt	$6.9B	$7.3B	$8.2B	$8.7B
Deferred income taxes	$181.0M	$343.0M	$361.0M	$383.0M
Other non-current liabilities	$2.1B	$2.1B	$2.1B	$1.8B
Total liabilities	$16.0B	$15.5B	$15.4B	$14.9B
Commitments and contingent liabilities	$0	$0	$0	$0
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1.5B	1.5B	1.5B	1.5B
Additional paid-in capital	$4.3B	$4.2B	$3.8B	$3.5B
Retained earnings	$26.6B	$26.1B	$25.3B	$24.6B
Accumulated other comprehensive income (loss)	($3.9B)	($4.2B)	($3.9B)	($4.1B)
Treasury stock, at cost	($28.4B)	($27.4B)	($26.0B)	($25.1B)
Total Colgate-Palmolive Company shareholders’ equity	$54.0M	$212.0M	$609.0M	$401.0M
Noncontrolling interests	$311.0M	$332.0M	$348.0M	$405.0M
Total equity	$365.0M	$544.0M	$957.0M	$806.0M
Total liabilities and equity	$16.3B	$16.0B	$16.4B	$15.7B

Colgate-Palmolive Co balance sheet, quarters

Line item	Jun 30, 2026	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025
Cash and cash equivalents	$1.4B	$1.3B	$1.3B	$1.2B
Receivables (net of allowances of $91 and $90, respectively)	$2.0B	$1.9B	$1.8B	$1.8B
Inventories	$2.2B	$2.1B	$2.1B	$2.1B
Other current assets	$795.0M	$772.0M	$844.0M	$888.0M
Total current assets	$6.3B	$6.1B	$6.0B	$6.0B
Cost	$11.0B	$10.9B	$10.8B	$10.7B
Less: Accumulated depreciation	($6.4B)	($6.3B)	($6.3B)	($6.1B)
Property, plant and equipment, net	$4.6B	$4.6B	$4.6B	$4.5B
Goodwill	$3.1B	$3.1B	$3.7B	$3.7B
Other intangible assets, net	$1.5B	$1.5B	$1.9B	$1.9B
Deferred income taxes	$221.0M	$211.0M	$216.0M	$218.0M
Other assets	$1.0B	$1.1B	$1.1B	$1.1B
Total assets	$16.8B	$16.6B	$17.5B	$17.5B
Debt payable within one-year	$34.0M	$36.0M	$1.1B	$1.6B
Accounts payable	$2.1B	$2.1B	$1.9B	$1.8B
Accrued income taxes	$410.0M	$444.0M	$339.0M	$321.0M
Other accruals	$3.6B	$3.4B	$3.2B	$3.0B
Total current liabilities	$6.1B	$5.9B	$6.5B	$6.8B
Long-term debt	$7.8B	$7.9B	$7.3B	$7.1B
Deferred income taxes	$201.0M	$198.0M	$304.0M	$279.0M
Other liabilities	$2.1B	$2.1B	$2.2B	$2.2B
Total liabilities	$16.2B	$16.1B	$16.3B	$16.4B
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1.5B	1.5B	1.5B	1.5B
Additional paid-in capital	$4.4B	$4.4B	$4.3B	$4.2B
Retained earnings	$27.1B	$26.8B	$27.1B	$26.7B
Accumulated other comprehensive income (loss)	($3.8B)	($3.9B)	($3.9B)	($3.9B)
Treasury stock, at cost	($28.9B)	($28.7B)	($28.1B)	($27.8B)
Total Colgate-Palmolive Company shareholders’ equity	$236.0M	$145.0M	$856.0M	$702.0M
Noncontrolling interests	$330.0M	$341.0M	$382.0M	$350.0M
Total equity	$566.0M	$486.0M	$1.2B	$1.1B
Total liabilities and equity	$16.8B	$16.6B	$17.5B	$17.5B

Cash flow statement

Colgate-Palmolive Co cash flow statement, fiscal years

Line item	Dec 31, 2025 · FY	Dec 31, 2024 · FY	Dec 31, 2023 · FY	Dec 31, 2022 · FY
Net income including noncontrolling interests	$2.3B	$3.0B	$2.5B	$2.0B
Depreciation and amortization	$630.0M	$605.0M	$567.0M	$545.0M
ERISA litigation matter	$65.0M	$0	$267.0M	—
Restructuring and termination benefits, net of cash	($7.0M)	$51.0M	($23.0M)	$49.0M
Stock-based compensation expense	$155.0M	$135.0M	$122.0M	$125.0M
Goodwill and intangible assets impairment charges	$919.0M	$0	$0	$721.0M
Deferred income taxes	($109.0M)	($77.0M)	($98.0M)	($78.0M)
Receivables	($16.0M)	($56.0M)	($37.0M)	($227.0M)
Inventories	$109.0M	($100.0M)	$194.0M	($333.0M)
Accounts payable and other working capital	$251.0M	—	—	—
Other non-current assets	$35.0M	—	—	—
Other non-current liabilities	($95.0M)	—	—	—
Net cash provided by operations	$4.2B	$4.1B	$3.7B	$2.6B
Capital expenditures	($564.0M)	($561.0M)	($705.0M)	($696.0M)
Purchases of marketable securities and investments	($698.0M)	($574.0M)	($506.0M)	($470.0M)
Proceeds from sale of marketable securities and investments	$752.0M	$564.0M	$502.0M	$322.0M
Payment for acquisitions, net of cash acquired	($293.0M)	$0	$0	($809.0M)
Other investing activities	($14.0M)	$37.0M	($33.0M)	$5.0M
Net cash used in investing activities	($817.0M)	($534.0M)	($742.0M)	($1.6B)
Short-term borrowing (repayment) less than 90 days, net	($989.0M)	$93.0M	($906.0M)	$540.0M
Principal payments on debt	($655.0M)	($503.0M)	($903.0M)	($406.0M)
Proceeds from issuance of debt	$1.2B	$2.0M	$1.5B	$1.5B
Dividends paid	($1.8B)	($1.8B)	($1.7B)	($1.7B)
Purchases of treasury shares	-1.2B	-1.7B	-1.1B	-1.3B
Proceeds from exercise of stock options	$101.0M	$638.0M	$380.0M	$418.0M
Other financing activities	$132.0M	($91.0M)	$18.0M	($18.0M)
Net cash used in financing activities	($3.3B)	($3.4B)	($2.8B)	($952.0M)
Effect of exchange rate changes on Cash and cash equivalents	$67.0M	($54.0M)	($19.0M)	($60.0M)
Net increase (decrease) in Cash and cash equivalents	$192.0M	$130.0M	$191.0M	($57.0M)
Cash and cash equivalents at beginning of year	$1.1B	$966.0M	$775.0M	$832.0M
Cash and cash equivalents at end of year	$1.3B	$1.1B	$966.0M	$775.0M
Income taxes paid	$913.0M	$933.0M	$937.0M	$945.0M
Interest paid	$270.0M	$302.0M	$280.0M	$151.0M

Colgate-Palmolive Co cash flow statement, quarters

Line item	Jun 30, 2026 · YTD	Mar 31, 2026 · Q1	Sep 30, 2025 · YTD	Jun 30, 2025 · YTD
Net income including noncontrolling interests	$1.4B	$681.0M	$2.3B	$1.5B
Depreciation and amortization	$311.0M	$156.0M	$457.0M	$299.0M
ERISA litigation matter	$0	$0	$65.0M	$65.0M
Restructuring and termination benefits, net of cash	$232.0M	$165.0M	($15.0M)	($13.0M)
Stock-based compensation expense	$78.0M	$40.0M	$127.0M	$55.0M
Deferred income taxes	($15.0M)	($18.0M)	$8.0M	($17.0M)
Receivables	($274.0M)	($215.0M)	($180.0M)	($152.0M)
Inventories	($110.0M)	($41.0M)	$9.0M	$3.0M
Accounts payable and other working capital	$124.0M	($11.0M)	—	—
Other non-current assets	$47.0M	$19.0M	—	—
Other non-current liabilities	($52.0M)	($29.0M)	—	—
Net cash provided by (used in) operations	$1.7B	$747.0M	$2.7B	$1.5B
Capital expenditures	($266.0M)	($138.0M)	($387.0M)	($232.0M)
Purchases of marketable securities and investments	($124.0M)	($70.0M)	($537.0M)	($384.0M)
Proceeds from sale of marketable securities and investments	$150.0M	$94.0M	$508.0M	$350.0M
Payment for acquisition, net of cash acquired	$0	—	($293.0M)	($293.0M)
Other investing activities	($4.0M)	($8.0M)	($5.0M)	($1.0M)
Net cash provided by (used in) investing activities	($244.0M)	($122.0M)	($714.0M)	($560.0M)
Short-term borrowing (repayment) less than 90 days, net	$1.1B	$1.1B	$139.0M	($30.0M)
Principal payments of debt	($1.1B)	($1.1B)	($655.0M)	($139.0M)
Proceeds from issuance of debt	$0	—	$497.0M	$497.0M
Dividends paid	($879.0M)	($417.0M)	($1.3B)	($880.0M)
Purchases of treasury shares	-597.0M	-306.0M	-804.0M	-516.0M
Proceeds from exercise of stock options	$138.0M	$127.0M	$83.0M	$65.0M
Other financing activities	($43.0M)	($23.0M)	$145.0M	$136.0M
Net cash provided by (used in) financing activities	($1.4B)	($563.0M)	($1.9B)	($867.0M)
Effect of exchange rate changes on Cash and cash equivalents	($2.0M)	($15.0M)	$47.0M	$62.0M
Net increase (decrease) in Cash and cash equivalents	$82.0M	$47.0M	$183.0M	$119.0M
Cash and cash equivalents at beginning of the period	$1.3B	$1.3B	$1.1B	$1.1B
Cash and cash equivalents at end of the period	$1.4B	$1.3B	$1.3B	$1.2B
Income taxes paid	$459.0M	$176.0M	$712.0M	$530.0M
Interest paid	$127.0M	$96.0M	$235.0M	$137.0M

Colgate-Palmolive Co score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.